A one-pot asymmetric ERA-CRISPR/Cas12a assay for visual detection of white spot syndrome virus in shrimp
Frontiers in Cellular and Infection Microbiology · 2026-11-12 · 16
DOI: 10.3389/fcimb.2026.1978490 ↗Abstract
Introduction White spot syndrome virus (WSSV) threatens shrimp aquaculture. PCR is sensitive but laboratory dependent. Isothermal amplification with CRISPR/Cas12a offers an alternative, but one-pot integration is limited by competition between double-stranded amplicons and crRNA for Cas12a. Methods A one-pot assay (OAERA-Cas12a) integrating asymmetric enzymatic recombinase amplification (aERA) with CRISPR/Cas12a was developed. Key parameters were optimized. Analytical specificity was tested against common non-target shrimp pathogens. Sensitivity was determined using plasmid standards. Diagnostic performance was evaluated on 57 samples from farm submissions and a proficiency-testing programme. qPCR was used for comparison. Results Optimal conditions were determined to be 1:120 primer ratio, 1 µM Cas12a, 4:1 Cas12a-to-crRNA, and 46 °C. No cross-reactivity was observed in the tested panel. The approximate plasmid-based LoD was determined to be 10 copies/µL (24/25 technical replicates, 96%, exact 95% CI 79.7–99.9%); 25/25 replicates were positive at 50 copies/µL. Because the lower CI bound was below 95%, a ≥95% detection probability was not established with high precision. The readout was completed within 15 min. Agreement with qPCR was observed for OAERA-Cas12a: 9/9 positive (100%, 95% CI 66.4-100%), 48/48 negative (100%, 95% CI 92.6-100%), and 57/57 overall (100%, 95% CI 93.7-100%). Conclusions OAERA-Cas12a enables laboratory-based WSSV detection in a simple one-pot format. These results provide a basis for further development toward field deployment and point-of-care testing. Independent validation remains necessary to establish field reliability, point-of-care performance, and suitability for routine surveillance.
EUVIMED